wada350.JPG

和田 仁

南東北がん陽子線治療センター・副センター長

  • 現職

    • 南東北がん陽子線治療センター・副センター長

  • 教育歴・卒後研修歴

    • 1999

      東北大学医学部卒

    • 2003 

      東北大学大学院・医学研究科・医学博士

       

  • 専門医資格等

    • 1997

      日本医学放射線学会・放射線専門医

       

    • 1998

      日本放射線腫瘍学会・放射線治療専門医

  • 職歴

    • 1990-1993

       

      長井市立総合病院 (現・公立置賜総合病院)・研修医

    • 1993-1995

      東北大学医学部放射線医学講座・助教

    • 1995-1997

      いわき市立総合磐城共立病院 (現・いわき市医療センター)・放射線科・医師

    • 1997-1999

      東北大学医学部放射線学講座・講師

    • 1999-2002

      竹田総合病院放射線科・医長

    • 2002-2004

      山形市立病院済生館・放射線科・医長

    • 2004-2005

      山形大学医学部放射線学講座・講師

    • 2005-2006

      山形大学医学部放射線医学講座・准教授

    • 2006-2011

      山形大学医学部放射線医学講座・放射線腫瘍学分野・准教授

    • 2008-2011

      山形大学医学部東北未来がん医療学講座・准教授

    • 2011-2015

      宮城県立がんセンター・放射線治療科・医療部長

    • 2015-2018

      南東北がん陽子線治療センター・診療所所長

    • 2018-present

      南東北がん陽子線治療センター・副センター長

  • 専門医療分野

    • 放射線腫瘍学
    • がんの陽子線治療

  • 学会活動等

    • 日本医学放射線学会
    • 日本放射線腫瘍学会
    • 日本緩和医療学会

  • 近著・論文

    • Wada H, Nemoto K, Nomiya T, Muramkami M, Suzuki M, Kuroda Y, Ichikawa M, Ota I, Hagiwara Y, Ariga H, Takeda K, Takai K, Fujimoto K, Kenjo M, Ogawa K. A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrent rectal cancer. Int J Clin Oncol 2013; 18(2): 273-8
    • Wada H, Nemoto K, Ogawa Y, Hareyama M, Yoshida H, Takamura A, Ohmori K, Hamamoto Y, Sugita T, Saitoh M, Yamada S. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys 2004; 59(2): 495-500
    • Wada H, Takai Y, Nemoto K, Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 2004; 58(4): 1114-20
    • Ono T, Hareyama M, Nakamura T, Kimura K, Hayashi Y, Azami Y, Hirose K, Hatayama Y, Suzuki M, Wada H, Kikuchi Y, Nemoto K. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience. Radiat Oncol 2016; 11: 56
    • Hatayama Y, Nakamura T, Suzuki M, Azami Y, Ono T, Yabuuchi T, Hayashi Y, Kimura K, Hirose K, Wada H, Hareyama M, Kikuchi Y, Takai Y. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer. Clin Lung Cancer 2016; 17(5): 427-432
    • Kosugi T, Shikama N, Saito T, Nakamura N, Nakura A, Harada H, Wada H, Nozaki M, Uchida N, Nakamura K. A Nationwide Survey in Japan of Palliative Radiotherapy for Bleeding in Gastrointestinal and Genitourinary Tumor Patients World J Oncol. 2016; 7(2-3): 29-33
    • Hayashi Y, Nakamura T, Mitsudo K, Kimura K, Yamaguchi H, Ono T, Azami Y, Takayama K, Hirose K, Yabuuchi T, Suzuki M, Hatayama Y, Kikuchi Y, Wada H, Fuwa N, Hareyama M, Tohnai I. Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer. Asia Pac J Clin Oncol 2016 May 25
    • Ariga T, Toita T, Kato S, Kazumoto T, Kubozono M, Tokumaru S, Eto H, Nishimura T, Niibe Y, Nakata K, Kaneyasu Y, Nonoshita T, Uno T, Ohno T, Iwata H, Harima Y, Wada H, Yoshida K, Gomi H, Numasaki H, Teshima T, Yamada S, Nakano T. Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study. J Radiat Res 2015; 56(5): 841-8
    • Imai T, Matsuura K, Asada Y, Sagai S, Katagiri K, Ishida E, Saito D, Sadayasu R, Wada H, Saijo S. Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy. Jpn J Clin Oncol 2014; 44(5): 422-7
    • Nakamura N., Shikama N., Wada H., Harada H., Nozaki M., Nagakura H., Tago M., Oguchi M., Uchida N. and the Japanese Radiation Oncology Study Group Working Subgroup of Palliative Radiotherapy. Patterns of Practice in Palliative Radiotherapy for Painful Bone Metastases: A Survey in Japan. Int J Radiat Oncol Biol Phys 2012; 83: e117-20
    • Ogawa K., Karasawa K., Ito Y., Ogawa Y., Jingu K., Onishi H., Aoki S., Wada H., Kokubo M., Ogo E., Etoh H., Kazumoto T., Takayama M., Nemoto K., and Nishimura Y. ：JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 2011; 80: 111-118
    • Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys 2010; 77(3): 734-42
    • Nomiya T, Teruyama K, Wada H, Nemoto K. Time course of pain relief in patients treated with radiotherapy for cancer pain: a prospective study. Clin J Pain 2010; 26(1): 38-42
    • Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S Long-Term Results of Radiotherapy for T1a and T1bN0M0 Glottic Carcinoma Laryngoscope 2008; 118: 1417-1421
    • Nomiya T, Teruyama K, Wada H, Nemoto K. Chemoradiotherapy for a patient with a giant esophageal fistula. World J Gastroenterol 2007; 13(15): 2250-4
    • Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma. Ann Otol Rhinol Laryngol 2006; 115(10): 727-32
    • Nemoto K, Takai K, Ogawa Y, Sakayauchi T, Sugawara T, Jingu K, Wada H, Takai Y, Yamada S. Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection. Int J Radiat Oncol Biol Phys 2005; 63(5): 1290-4
    • Nemoto K, Takai Y, Ogawa Y, Kakuto Y, Ariga H, Matsushita H, Wada H, Yamada S Fetal hemorrhage in irradiated esophageal cancer patients. Acta Oncol 37: 259-262, 1998
Back
Printer Friendly